Array
(
[a_id] => 238915
[c_id] => 11
[r_id] => 0
[rr_id] => 0
[m_id] => 0
[s_id] => 25646
[id_id] => 0
[v_id] => 0
[loc_id] => 0
[ft_id] => 0
[a_classification] => news
[a_layout] => 1
[a_headline] => NIAID Division of AIDS Chief Sees 'Growing Interest' in AIDS Cure
[a_sheadline] => NIAID Division of AIDS Chief Sees 'Growing Interest' in AIDS Cure
[a_slug] => niaid-division-aids-chief-sees-growing-interest-aids-cure-238915
[a_subheadline] =>
[a_summary] => Dr. Carl Dieffenbach, the director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases says he has seen a “growing interest” for an AIDS cure over the past three to four years.
[a_article] =>
Dr. Carl Dieffenbach, the director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases says he has seen a “growing interest” for an AIDS cure over the past three to four years.
He told Medical Daily in a phone interview on Wednesday that there has been a 7 to 8 percent growth each year in number of applications to his agency for grants seeking funding for cure research.
He suggests that there could have been more application for grants, but because of the economy, research in the area has lost momentum.
Dieffenbach estimates that around 3 percent of the NIAID budget goes to this area of development.
In May, Dieffenbach, along with Dr. Anthony Fauci, the director of the NIAID, wrote in the Annals of Internal Medicine that as a result of successes over the last 30 years in understanding, treating and preventing HIV infection and AIDS “it is now time to focus on future challenges.”
He said the challenges included “efficiently identifying a maximum number of HIV-infected persons through voluntary HIV testing and initiating antiretroviral therapy (ART)," developing a cure for HIV infection to alleviate the need for lifelong ART, and preventing new cases of infection.
“It’s more about improving treatment as opposed to replacing treatment,” he told Medical Daily.
NIAID, which says a cure is one of its top priorities, in 2011 gave grants that may total $70 million over five years to three research teams in the quest to find a cure.
California’s stem-cell agency in October committed a total of $38 million to three projects intended to find a cure.
Sustainability of Current Treatments
One researcher wonders if the current approach to treating HIV and AIDS is sustainable for the growing population of infected people. There are already tens of millions who are infected. Treatments are expensive, and infected people must take medication every day.
“I don’t think the world has the resources to deliver these drugs to everyone who needs them for decades,” Dr. Steven Deeks, a professor of medicine at the University of California, San Francisco, told The New York Times last week.
Hope for a Cure
It wasn’t until 2007 that many started believing that a cure for AIDS could be found, after one patient was essentially cured of the disease.
In that year, Timothy Brown, who had H.I.V. and leukemia, received bone-marrow transplants to treat his leukemia from a donor who happened to be naturally resistant to H.I.V. infection. His immune system was replaced by one that was resistance to the infection.
Another case that added hope to finding a cure was more recent. After a undergoing a gene therapy procedure, a 50-year-old man in Trenton, NJ was able to temporarily control the AIDS virus when he stopped taking the usual antiviral drugs.
Correction:In an article posted on December 7, Dr. Carl Dieffenbach was incorrectly identified as the director of NIAID. He is the NAIAD Division Director for AIDS. Dr. Anthony Fauci is the Director of NIAID.
Chinese medical staff test blood samples for HIV/AIDS at a disease prevention and control centre in Nanchang in eastern China's Jiangxi province in a file photo.China Daily / Reuters
[a_content] =>
Dr. Carl Dieffenbach, the director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases says he has seen a “growing interest” for an AIDS cure over the past three to four years.
He told Medical Daily in a phone interview on Wednesday that there has been a 7 to 8 percent growth each year in number of applications to his agency for grants seeking funding for cure research.
He suggests that there could have been more application for grants, but because of the economy, research in the area has lost momentum.
Dieffenbach estimates that around 3 percent of the NIAID budget goes to this area of development.
In May, Dieffenbach, along with Dr. Anthony Fauci, the director of the NIAID, wrote in the Annals of Internal Medicine that as a result of successes over the last 30 years in understanding, treating and preventing HIV infection and AIDS “it is now time to focus on future challenges.”
He said the challenges included “efficiently identifying a maximum number of HIV-infected persons through voluntary HIV testing and initiating antiretroviral therapy (ART)," developing a cure for HIV infection to alleviate the need for lifelong ART, and preventing new cases of infection.
“It’s more about improving treatment as opposed to replacing treatment,” he told Medical Daily.
NIAID, which says a cure is one of its top priorities, in 2011 gave grants that may total $70 million over five years to three research teams in the quest to find a cure.
California’s stem-cell agency in October committed a total of $38 million to three projects intended to find a cure.
Sustainability of Current Treatments
One researcher wonders if the current approach to treating HIV and AIDS is sustainable for the growing population of infected people. There are already tens of millions who are infected. Treatments are expensive, and infected people must take medication every day.
“I don’t think the world has the resources to deliver these drugs to everyone who needs them for decades,” Dr. Steven Deeks, a professor of medicine at the University of California, San Francisco, told The New York Times last week.
Hope for a Cure
It wasn’t until 2007 that many started believing that a cure for AIDS could be found, after one patient was essentially cured of the disease.
In that year, Timothy Brown, who had H.I.V. and leukemia, received bone-marrow transplants to treat his leukemia from a donor who happened to be naturally resistant to H.I.V. infection. His immune system was replaced by one that was resistance to the infection.
Another case that added hope to finding a cure was more recent. After a undergoing a gene therapy procedure, a 50-year-old man in Trenton, NJ was able to temporarily control the AIDS virus when he stopped taking the usual antiviral drugs.
Correction:In an article posted on December 7, Dr. Carl Dieffenbach was incorrectly identified as the director of NIAID. He is the NAIAD Division Director for AIDS. Dr. Anthony Fauci is the Director of NIAID.
[a_content_last] =>
[a_aside] =>
[a_content_first_type] => imageBox
[a_content_last_type] =>
[a_content_embed] =>
[image] => Array
(
[id_id] => 222273
[id_name] => Chinese medical staff
[id_caption] => Chinese medical staff test blood samples for HIV/AIDS at a disease prevention and control centre in Nanchang in eastern China's Jiangxi province in a file photo.
[id_short_caption] =>
[id_credit] => China Daily / Reuters
[id_keyword] =>
[id_gallery] =>
[id_adult] => 0
[id_hide] => 0
[id_source] =>
[id_photographer] =>
[id_text] =>
[id_ext] => jpg
[id_location] =>
[id_width] => 670
[id_height] => 454
[id_left] => 50
[id_top] => 40
[id_quality] => 85
[id_filesize] => 37658
[s_id] =>
[m_id] => 1
[x_id] => 0
[id_time] => 2011-12-08 16:32:35
[id_submittedTime] => 2011-12-08 16:32:35
[id_url] =>
[id_published] => 1
[img_name] => public://2013/08/04/0/24/2410.jpg
[ori] => https://d.medicaldaily.com/en/full/222273/chinese-medical-staff.jpg
[src] => https://d.medicaldaily.com/en/full/222273/chinese-medical-staff.jpg
[tag] => src="https://d.medicaldaily.com/en/full/222273/chinese-medical-staff.jpg" alt="Chinese medical staff"
[picture] =>
)
[images] => Array
(
[0] => Array
(
[id_id] => 222273
[id_name] => Chinese medical staff
[id_caption] => Chinese medical staff test blood samples for HIV/AIDS at a disease prevention and control centre in Nanchang in eastern China's Jiangxi province in a file photo.
[id_short_caption] =>
[id_credit] => China Daily / Reuters
[id_keyword] =>
[id_gallery] =>
[id_adult] => 0
[id_hide] => 0
[id_source] =>
[id_photographer] =>
[id_text] =>
[id_ext] => jpg
[id_location] =>
[id_width] => 670
[id_height] => 454
[id_left] => 50
[id_top] => 40
[id_quality] => 85
[id_filesize] => 37658
[s_id] =>
[m_id] => 1
[x_id] => 0
[id_time] => 2011-12-08 16:32:35
[id_submittedTime] => 2011-12-08 16:32:35
[id_url] =>
[id_published] => 1
[img_name] => public://2013/08/04/0/24/2410.jpg
[ori] => https://d.medicaldaily.com/en/full/222273/chinese-medical-staff.jpg
[src] => https://d.medicaldaily.com/en/full/222273/chinese-medical-staff.jpg
[tag] => src="https://d.medicaldaily.com/en/full/222273/chinese-medical-staff.jpg" alt="Chinese medical staff"
[picture] =>
)
)
[a_adult] => 0
[mainCat] => Array
(
[c_id] => 11
[c_type] => 1
[c_name] => Conditions
[c_slug] => conditions
[c_ancestry] => -11-
[c_ancestry_slug] =>
[c_parent_id] => 0
[x_id] => 0
[c_text] =>
The study also revealed that individuals who quit smoking, regardless of age, can achieve a life expectancy similar to non-smokers within approximately 10 years after quitting, and nearly half of this benefit can be noticed within just three years.
Researchers found that a combination of genetics and environmental factors reduces longevity in dementia patients. The same combination may shorten the lives of their siblings even without dementia.
The suicide rates increase substantially when air pollution rises, and the effect was particularly strong in the elderly, with older women 2.5 times more at risk than other groups.
While mental stress is commonly acknowledged in connection with grief, it is crucial to understand that grief can also present physical symptoms, including illnesses, fatigue, pain, and sleep disturbances.
The use of antidepressants, particularly fluoxetine, could affect the development of the prefrontal cortex of the infant's brain, potentially raising the risk of mental health disorders later in their life.
Researchers have developed smart earrings that could continuously monitor a person's earlobe temperature. The innovation known as Thermal Earring could also be potentially used to track signs of ovulation, stress, eating, and exercise.
The researchers made the interesting finding using a trial involving patients with a rare genetic condition called Alpha-1 antitrypsin deficiency (AATD).
People infected with the flu were more likely to need hospital care in the following year for common neurologic conditions than people who had the SARS-CoV2 infection.
Among women with a history of pregnancy complications, those who achieved or maintained high heart health after pregnancy were at a similar risk for heart disease as women without adverse pregnancy outcomes and good cardiovascular health, the study stated.
The study published in the journal BMJ indicated that individuals with hypermobile joints had a 30% higher chance of not fully recovering from COVID-19 and experiencing persistent fatigue associated with long COVID.
The studies showed that COVID antigens lingered in the blood up to 14 months after infection and more than two years in tissue samples of people who had the infection.
Those individuals who receive a COVID-19 vaccine during the first half of their menstrual cycle are more likely to experience cycle length changes than those receiving a vaccine in the latter half.
NIAID Division of AIDS Chief Sees 'Growing Interest' in AIDS Cure
By
Chinese medical staff test blood samples for HIV/AIDS at a disease prevention and control centre in Nanchang in eastern China's Jiangxi province in a file photo.China Daily / Reuters
Dr. Carl Dieffenbach, the director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases says he has seen a “growing interest” for an AIDS cure over the past three to four years.
He told Medical Daily in a phone interview on Wednesday that there has been a 7 to 8 percent growth each year in number of applications to his agency for grants seeking funding for cure research.
He suggests that there could have been more application for grants, but because of the economy, research in the area has lost momentum.
Dieffenbach estimates that around 3 percent of the NIAID budget goes to this area of development.
In May, Dieffenbach, along with Dr. Anthony Fauci, the director of the NIAID, wrote in the Annals of Internal Medicine that as a result of successes over the last 30 years in understanding, treating and preventing HIV infection and AIDS “it is now time to focus on future challenges.”
He said the challenges included “efficiently identifying a maximum number of HIV-infected persons through voluntary HIV testing and initiating antiretroviral therapy (ART)," developing a cure for HIV infection to alleviate the need for lifelong ART, and preventing new cases of infection.
“It’s more about improving treatment as opposed to replacing treatment,” he told Medical Daily.
NIAID, which says a cure is one of its top priorities, in 2011 gave grants that may total $70 million over five years to three research teams in the quest to find a cure.
California’s stem-cell agency in October committed a total of $38 million to three projects intended to find a cure.
Sustainability of Current Treatments
One researcher wonders if the current approach to treating HIV and AIDS is sustainable for the growing population of infected people. There are already tens of millions who are infected. Treatments are expensive, and infected people must take medication every day.
“I don’t think the world has the resources to deliver these drugs to everyone who needs them for decades,” Dr. Steven Deeks, a professor of medicine at the University of California, San Francisco, told The New York Times last week.
Hope for a Cure
It wasn’t until 2007 that many started believing that a cure for AIDS could be found, after one patient was essentially cured of the disease.
In that year, Timothy Brown, who had H.I.V. and leukemia, received bone-marrow transplants to treat his leukemia from a donor who happened to be naturally resistant to H.I.V. infection. His immune system was replaced by one that was resistance to the infection.
Another case that added hope to finding a cure was more recent. After a undergoing a gene therapy procedure, a 50-year-old man in Trenton, NJ was able to temporarily control the AIDS virus when he stopped taking the usual antiviral drugs.
Correction:In an article posted on December 7, Dr. Carl Dieffenbach was incorrectly identified as the director of NIAID. He is the NAIAD Division Director for AIDS. Dr. Anthony Fauci is the Director of NIAID.
